Treatment of iron deficiency aneamia in femals
Reading File
Finding Sources
Finding Sources
Reading File
Finding Sources
Reading File
Reading File
Reading File
Reading File
I now have comprehensive information from multiple authoritative textbooks to provide a thorough answer. Here is the treatment of iron deficiency anaemia (IDA) in females:
Treatment of Iron Deficiency Anaemia in Females
Background & Common Causes in Females
Iron deficiency is the most common nutritional deficiency worldwide. In females, the predominant causes are:
- Menstruation (the most common benign physiologic reason in premenopausal women)
- Pregnancy (increased iron demand)
- Dietary deficiency
- Chronic/occult blood loss
Important note: Postmenopausal women presenting with IDA without overt bleeding should be evaluated with endoscopy and colonoscopy, as GI malignancy or pathology is more likely. Premenopausal women with IDA can typically be attributed to menstrual losses. — Lippincott Illustrated Reviews: Pharmacology
Step 1 — Identify and Treat the Underlying Cause
Treatment of IDA is not complete without addressing the root cause (e.g., managing heavy menstrual bleeding, correcting dietary deficiency, investigating GI blood loss).
Step 2 — Oral Iron Therapy (First-Line)
Oral iron is the standard first-line treatment for most patients.
Dosing
- Standard dose: 60–120 mg/day of elemental iron in divided doses, 2–3 times daily
- Pregnant women: 30 mg/day is adequate to meet increased nutritional needs (even with normal Hb/Hct); up to 120 mg may be given 4× daily for rapid response to ongoing loss
- Every-other-day dosing is emerging as equally effective and better tolerated — higher daily doses paradoxically decrease absorption by raising hepcidin levels
- Once-daily ferrous sulfate 325 mg on an empty stomach maximises absorption and tolerance
Hemoglobin recovery rate: ~2 g/L/day; full normalisation typically takes 1–2 months. Iron stores require several more months of therapy to replenish.
Oral Iron Preparations
| Formulation | Elemental Iron (%) | Notes |
|---|---|---|
| Ferrous gluconate | 12% | Slightly less elemental iron; good tolerability |
| Ferrous sulfate | 20% | Most common, low cost |
| Ferrous sulfate (extended-release) | 30% | Once-daily dosing |
| Ferrous fumarate | 33% | Similar efficacy; minimal taste |
| Polysaccharide-iron complex | 100% | Tasteless; once-daily dosing |
| Carbonyl iron | 100% | Slower absorption → lower toxicity risk |
— Lippincott Illustrated Reviews: Pharmacology
Tips to Optimise Oral Absorption
- Take on an empty stomach
- Ascorbic acid (≥200 mg) co-administration increases absorption by ≥30% (though may worsen GI side effects)
- Avoid concurrent antacids or food — both reduce bioavailability
- Acidic gastric environment keeps iron in the ferrous (more soluble) form for duodenal absorption
Common Adverse Effects of Oral Iron
GI disturbances are the most frequent: nausea, heartburn, upper abdominal discomfort, constipation or diarrhea, and dark stools. Start at a low dose and titrate upward to improve adherence.
Step 3 — Intravenous (Parenteral) Iron
IV iron is indicated when:
- Oral iron is not tolerated (GI side effects)
- Malabsorption (e.g., coeliac disease, short bowel syndrome, post-bariatric surgery)
- Ongoing blood loss that cannot be managed orally
- Pregnancy with severe IDA requiring rapid repletion
- Patients on erythropoietin therapy
- Perioperative setting (patient blood management)
IV iron can replenish iron stores in 1–2 sessions, compared to months with oral therapy. — Goodman & Gilman's Pharmacological Basis of Therapeutics
Available IV Iron Formulations
| Agent | Key Notes |
|---|---|
| Ferric carboxymaltose | High-dose single infusion possible; widely used in pregnancy |
| Iron sucrose | Safer profile; requires multiple smaller doses |
| Sodium ferric gluconate | Multiple doses; good safety record |
| Iron dextran | Higher anaphylaxis risk; test dose mandatory |
| Ferumoxytol | Single large infusion (1.02 g); FDA-approved for CKD |
| Ferric derisomaltose | Single high-dose option |
Caution: Rare but potentially fatal hypersensitivity/anaphylactoid reactions can occur, especially with iron dextran. A test dose must be given before full iron dextran administration. IV iron should be used cautiously in active infection, as iron promotes bacterial growth. — Lippincott Illustrated Reviews: Pharmacology
Special Considerations in Pregnancy
- Iron deficiency anaemia is common in pregnancy due to expanded plasma volume and fetal demand
- Oral iron remains first-line
- IV ferric carboxymaltose has been studied in multiple RCTs and is preferred when oral iron fails or is not tolerated
- Physiologic (dilutional) anaemia without iron deficiency does not require iron therapy and does not worsen obstetric outcomes
- — Rosen's Emergency Medicine; Creasy & Resnik's Maternal-Fetal Medicine
Monitoring Response
- Reticulocyte count rises within 3–5 days of starting iron
- Haemoglobin should increase at ~2 g/L/day; full correction in 4–8 weeks
- Continue iron for 3–6 months after Hb normalises to replenish stores
- Iron stores (serum ferritin) are the last to recover
Summary Table
| Route | When to Use | Key Agents |
|---|---|---|
| Oral | First-line for most patients | Ferrous sulfate, fumarate, gluconate |
| IV | Intolerance, malabsorption, severe/rapid correction needed | Ferric carboxymaltose, iron sucrose, ferumoxytol |
| Dietary | Prevention; adjunct to supplementation | Red meat, legumes, leafy greens + vitamin C |
This is a shared conversation. Sign in to Orris to start your own chat.